Syngene buys Hyderabad operations in slump sale value of INR 4 billion
Syngene's operations in the Indian city of Hyderabad have been transferred to another wholly-armed arm of the company with effect from April 1,
Drugs
Pharma
Health
Medical
Pharma
U.S. to end Covid-19 curbs on May 11, migrant policy remains same
The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.
Drugs
Medical
Pharma
Lupin gets tentative nod for three HIV drugs
Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its
Drugs
Medical
Pharma
No ‘directed evolution research’ in COVID-19 vaccine: Pfizer
Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed
Drugs
Health
Pharma
Blood pressure drug may slow ageing in humans: Study
Studies on animals have shown that a drug used to treat hypertension prolongs the human lifespan and slows ageing, mimicking the effects of
Drugs
Medical
Pharma
COVID-19 to continue as public health emergency of international concern
COVID-19 will remain a pandemic as it continues to constitute a public health emergency of international concern, the WHO’s highest form of an
Drugs
Health
Pharma
NTD incidence fall by 80 million people, WHO chief calls for funds
The number of people affected by neglected tropical diseases (NTDs) has fallen by 80 million between 2020 and 2021, a WHO report stated.
Drugs
Medical
Pharma
Indian diagnostic firm Dr. Lal PathLabs acquires 10% of subsidiary
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL
Drugs
Medical
Pharma
Sun Pharma buys three anti-inflammatory drug brands from Aksigen
Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.
Drugs
Pharma
Dr. Reddy’s introduces Durezol in the US for eye treatment
Dr. Reddy's unveiled its difluprednate ophthalmic emulsion in the US market for treating inflammation and pain associated with eye surgery.